Woolsey has a proven team, proven strategy, and proven record. By repurposing existing drugs, Woolsey Pharmaceuticals is reinventing ways to treat some of the world’s most challenging diseases.
Investors 1
| Date | Name | Website |
| - | Nelstone V... | nelstoneve... |
Mentions in press and media 1
| Date | Title | Description |
| 19.06.2024 | Results of Woolsey Pharmaceuticals' Phase 2a Study of BRAVYL in ALS Patients Shows Statistically Significant Reduction in Neurofilament Light and Directionally Improved Clinical Outcomes | NEW YORK, June 19, 2024 /PRNewswire/ -- Woolsey Pharmaceuticals, a clinical-stage drug development company, announced that its investigational drug, BRAVYL, was well tolerated and exhibited statistically significant reductions in a key biom... |